Kinetics of Urinary Furosemide Elimination in Infants

Prandota, J; Houin, Georges

doi:10.1159/000457174

Cited by 6 publications

(7 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The author suggested that this was caused by competition between F and penicillin for renal tubular excretory mecha nisms. Similar observations were reported in infants recovering from pneu monia and respiratory insufficiency who received concomitantly F and cloxacillin or streptomycin [54]. After a few days of therapy with these antibiotics, the urinary elimination t% of F was found to be prolonged by about 100%.…”

Section: Decreased Elimination Of Drugssupporting

confidence: 82%

“…Studies with use of F in newborns and infants with right-sided heart insufficiency caused by fluid overload, respiratory distress syndrome, acute respiratory insufficiency accompa nying pneumonia, showed that the elimination t% of the drug was prolonged [53][54][55], This was connected with a longer diuretic effect of F in those chil dren [56],…”

Section: Decreased Elimination Of Drugsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Pharmacokinetics of Changes in Drug Elimination in Children

Prandota¹

1985

Dev Pharmacol Ther

View full text Add to dashboard Cite

This review mainly summarizes selected aspects of the present knowledge of drug elimination kinetics independent of developmental changes, with special attention given to clinical situations. The effects of different disease states, drug interactions, changes in urinary pH, induction of microsomal enzymes, competition for renal excretory mechanisms, possible enterohepatic recirculation, binding of drugs to tissues, effects of a drug on another drug’s metabolizing organ, and dose-dependent elimination, on increase or decrease of drug elimination rates in children, have been presented. Based on the available data it seems that one may postulate the following conclusions: (1) that the distribution factors as well as changes in drug elimination capacities seem to play a role, perhaps with differing relative importance, during each of the maturational periods; (2) that the physicochemical properties of a drug and its dosage, as well as changes in the volume of distribution in children, in the course of certain disease states may have a significant effect on kinetics of drug disposition in the body; (3) that systemic clearance, a model independent parameter, rather than elimination half-life, a hybrid pharmacokinetic parameter, more accurately reflects elimination of some drugs from the body; (4) that each drug and every clinical situation may require the evaluation of the direct effect on pharmacokinetic processes, since general principles may not always apply; (5) that drug disposition studies should also be performed, if possible, on patients under actual clinical situations and receiving the usual therapeutic regime, and (6) that the half-life of colistin is independent of postnatal age which should serve as a warning not to generalize about drug excretion in the young infant.

show abstract

Section: Decreased Elimination Of Drugssupporting

confidence: 82%

Section: Decreased Elimination Of Drugsmentioning

confidence: 99%

Clinical Pharmacokinetics of Changes in Drug Elimination in Children

Prandota¹

1985

Dev Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…[26][27][28]. Urine was collected by a natural voiding or, in a few patients, after indwelling catheter on a necessary basis, prior to receiving furosemide, and at hourly intervals for 6 h and then 6-8, 8-12 and 12-24 h thereafter.…”

Section: Methodsmentioning

confidence: 99%

“…Each urine specimen was measured for volume, and an aliquot was taken and stored in the dark at -20 °C for a few weeks until assayed. Urine samples containing furosemide were analyzed in duplicate by the fluorometric method as previously described [26,28].…”

Section: Methodsmentioning

confidence: 99%

“…The conditions present in the study groups included steroid-responsive nephrotic syndrome (NS) in group A; urinary tract infections (UTI) with mild hypertension in group B and miscellaneous diseases in infants in group C. Patients with congestive heart failure were not included in the study, but 5 of 12 infants were recovering from respiratory and cardiac insufficiency due to pneumonia. Detailed information concerning clinical, laboratory and pharmacokinetic data of all the studied patients have been published previously [26][27][28], In 10 of 34 patients, the study was performed twice, the first time within 24-48 h after admission to the hospital and the second at least 3 days later. Two patients with NS also received furosemide during subsequent hospitalizations.…”

Section: Patients Studiedmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacodynamic Determinants of Furosemide Diuretic Effect in Children

Prandota¹

1986

Dev Pharmacol Ther

Self Cite

View full text Add to dashboard Cite

The pharmacodynamics of 1 or 2 mg/kg of furosemide administered as a single dose orally or intravenously were studied in 34 hospitalized children (ranging in age from 9 days to 16.5 years) with normal renal function. These patients were divided into 3 groups: infants (furosemide 1 mg/kg, intravenously); children with steroid-responsive nephrotic syndrome (furosemide 2 mg/kg, orally and intravenously); patients with urinary tract infections and mild hypertension (furosemide 2 mg/kg, orally). A statistically significant positive linear relationship was found in these groups between the furosemide urinary excretion rate and urine flow rate, but log dose-response curves to furosemide were found to vary between the groups of patients studied. This variability reflects differences in the relationship between the amounts of furosemide reaching active sites and the pharmacodynamic effect of the drug. No sigmoid-shaped log dose-response curve (i.e., one approaching a zero response at very low furosemide urinary excretion rates, and a maximum response at very high excretion rates) was attained in this study. This suggests that the capacity of the kidney tubules to respond diuretically to the administered doses of furosemide was not exceeded in the studied patients. However, in the infants, a very steep log dose-response curve to a 1 mg/kg intravenous dose of furosemide suggests that higher doses may not result in a significant increase in diuretic response in infants with reasonably normal renal function. The lowest mean furosemide urinary excretion rate associated with significant diuresis was 0.58 ± 0.33 gg/kg/min. Also, a significant correlation was found between the amount (in milligrams), of furosemide excreted in the urine during the first 6 h after administration and the urine volume collected during that time (r = 0.71; p < 0.001; number of measurements = 43).

show abstract

The Pharmacology and Therapeutics of Diuretics in the Pediatric Patient

Wells

1990

Pediatric Clinics of North America

View full text Add to dashboard Cite

Kinetics of Urinary Furosemide Elimination in Infants

Cited by 6 publications

References 12 publications

Clinical Pharmacokinetics of Changes in Drug Elimination in Children

Clinical Pharmacokinetics of Changes in Drug Elimination in Children

Pharmacodynamic Determinants of Furosemide Diuretic Effect in Children

The Pharmacology and Therapeutics of Diuretics in the Pediatric Patient

Contact Info

Product

Resources

About